Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria.
Saved in:
| Title: | Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria. |
|---|---|
| Authors: | Gansane, Adama1 (AUTHOR) agansane.cnrfp@fasonet.bf, Lingani, Moussa2 (AUTHOR), Yeka, Adoke3 (AUTHOR), Nahum, Alain4 (AUTHOR), Bouyou-Akotet, Marielle5 (AUTHOR), Mombo-Ngoma, Ghyslain6,7,8 (AUTHOR), Kaguthi, Grace9 (AUTHOR), Barceló, Catalina10 (AUTHOR), Laurijssens, Bart11 (AUTHOR), Cantalloube, Cathy12 (AUTHOR), Macintyre, Fiona10 (AUTHOR), Djeriou, Elhadj12 (AUTHOR), Jessel, Andreas13 (AUTHOR), Bejuit, Raphaël12 (AUTHOR), Demarest, Helen10 (AUTHOR), Marrast, Anne Claire10 (AUTHOR), Debe, Siaka1 (AUTHOR), Tinto, Halidou2 (AUTHOR), Kibuuka, Afizi3 (AUTHOR), Nahum, Diolinda4 (AUTHOR) |
| Source: | Malaria Journal. 1/3/2023, Vol. 22 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
